Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash#United_States#Azitra#Branford#ATR-04#EGFR_inhibitors
Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash
Azitra, Inc. has advanced to Cohort 2 in its ATR-04 Phase 1/2 clinical trial, addressing skin rashes caused by cancer treatments with positive safety data.
third-news.com
October 1, 2026 at 12:14 PM
Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash#United_States#Azitra#Branford#ATR-04#EGFR_inhibitors
#AZTR Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 1, 2026 at 12:00 PM
#AZTR Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
🚀 Zacks Small Cap Research - AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
September 29, 2026 at 5:45 AM
🚀 Zacks Small Cap Research - AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
🚨 $AZTR
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
SEC Filing: AZTR
Click to view the official SEC document.
www.sec.gov
September 28, 2026 at 8:50 PM
🚨 $AZTR
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference#United_States#New_York#biotechnology#Azitra#ATR-COSF
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference
Azitra, Inc. will participate in the H.C. Wainwright Annual Conference, where it will present key developments in its biopharmaceutical pipeline and innovative research.
third-news.com
September 8, 2026 at 12:16 PM
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference#United_States#New_York#biotechnology#Azitra#ATR-COSF
🚨 $AZTR
On September 8, 2026, Azitra, Inc. issued a press release announcing that it will provide a virtual presentation at the H.C. Wainwright 28 th Annual Global Investment Conference.
On September 8, 2026, Azitra, Inc. issued a press release announcing that it will provide a virtual presentation at the H.C. Wainwright 28 th Annual Global Investment Conference.
SEC Filing: AZTR
Click to view the official SEC document.
www.sec.gov
September 8, 2026 at 12:06 PM
🚨 $AZTR
On September 8, 2026, Azitra, Inc. issued a press release announcing that it will provide a virtual presentation at the H.C. Wainwright 28 th Annual Global Investment Conference.
On September 8, 2026, Azitra, Inc. issued a press release announcing that it will provide a virtual presentation at the H.C. Wainwright 28 th Annual Global Investment Conference.
#AZTR Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 8, 2026 at 12:00 PM
#AZTR Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
Azitra, Inc. Achieves NYSE American Compliance and Focuses on Growth in Innovative Dermatology#Azitra#NYSE_American#ATR-COSF
Azitra, Inc. Achieves NYSE American Compliance and Focuses on Growth in Innovative Dermatology
Azitra, Inc. has successfully regained compliance with NYSE American standards, allowing it to focus on advancing innovative treatments in dermatology and cosmetics.
third-news.com
August 21, 2026 at 12:10 PM
Azitra, Inc. Achieves NYSE American Compliance and Focuses on Growth in Innovative Dermatology#Azitra#NYSE_American#ATR-COSF
🚨 $AZTR
On August 21, 2026, Azitra, Inc. issued a press release announcing that on August 19, 2026, the Company received a letter from NYSE Regulation confirming that the Company has regained compliance with the continued listing standards of the NYSE American LLC . A copy of the press release is...
On August 21, 2026, Azitra, Inc. issued a press release announcing that on August 19, 2026, the Company received a letter from NYSE Regulation confirming that the Company has regained compliance with the continued listing standards of the NYSE American LLC . A copy of the press release is...
SEC Filing: AZTR
Click to view the official SEC document.
www.sec.gov
August 21, 2026 at 12:06 PM
🚨 $AZTR
On August 21, 2026, Azitra, Inc. issued a press release announcing that on August 19, 2026, the Company received a letter from NYSE Regulation confirming that the Company has regained compliance with the continued listing standards of the NYSE American LLC . A copy of the press release is...
On August 21, 2026, Azitra, Inc. issued a press release announcing that on August 19, 2026, the Company received a letter from NYSE Regulation confirming that the Company has regained compliance with the continued listing standards of the NYSE American LLC . A copy of the press release is...
#AZTR Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
https://www.stocktitan.net/news/AZTR/azitra-inc-regains-compliance-with-nyse-american-continued-listing-egntdihidubg.html
https://www.stocktitan.net/news/AZTR/azitra-inc-regains-compliance-with-nyse-american-continued-listing-egntdihidubg.html
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
BRANFORD, Conn., Aug. 21, 2026/ PRNewswire/-- Azitra, Inc., a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins and peptides, today announced that it has received written notification from NYSE American LLC confirming that the Company has regained compliance with...
www.stocktitan.net
August 21, 2026 at 12:00 PM
#AZTR Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
https://www.stocktitan.net/news/AZTR/azitra-inc-regains-compliance-with-nyse-american-continued-listing-egntdihidubg.html
https://www.stocktitan.net/news/AZTR/azitra-inc-regains-compliance-with-nyse-american-continued-listing-egntdihidubg.html
Azitra (NYSEAMERICAN:AZTR) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
Azitra (NYSEAMERICAN:AZTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05),…
Azitra (NYSEAMERICAN:AZTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05),…
Azitra (NYSEAMERICAN:AZTR) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
Azitra (NYSEAMERICAN:AZTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05), FiscalAI reports. Azitra Stock Performance Shares of Azitra stock opened at $0.14 on Friday. Azitra has a 12-month low of $0.10 and a 12-month high of [...]
news-area.com
August 15, 2026 at 12:57 AM
Azitra (NYSEAMERICAN:AZTR) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
Azitra (NYSEAMERICAN:AZTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05),…
Azitra (NYSEAMERICAN:AZTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.05),…
The piece I finished. Only took me about 20~ish hours. The actual attack is so minimal compared to this. 😹
August 13, 2026 at 8:56 AM
The piece I finished. Only took me about 20~ish hours. The actual attack is so minimal compared to this. 😹
Azitra, Inc. Reports Strong Q2 2026 Results and Strategic Business Developments#United_States#Azitra#Branford#ATR-04#ATR-COSF
Azitra, Inc. Reports Strong Q2 2026 Results and Strategic Business Developments
Azitra, Inc., a clinical stage biopharmaceutical company, announces promising Q2 2026 results alongside significant business updates focusing on precision dermatology.
third-news.com
August 12, 2026 at 9:25 PM
Azitra, Inc. Reports Strong Q2 2026 Results and Strategic Business Developments#United_States#Azitra#Branford#ATR-04#ATR-COSF
🚨 $AZTR
On August 12, 2026 , Azitra, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
On August 12, 2026 , Azitra, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
SEC Filing: AZTR
Click to view the official SEC document.
www.sec.gov
August 12, 2026 at 9:19 PM
🚨 $AZTR
On August 12, 2026 , Azitra, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
On August 12, 2026 , Azitra, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
#AZTR Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-q2-2026-results-and-provides-business-u3pdcnnwyut6.html
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-q2-2026-results-and-provides-business-u3pdcnnwyut6.html
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
BRANFORD, Conn., Aug. 12, 2026/ PRNewswire/-- Azitra, Inc., a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins and peptides, today reported financial results for the quarter ended June 30, 2026, and provided a business update. Q2 2026 and Recent Business Highlights.
www.stocktitan.net
August 12, 2026 at 9:00 PM
#AZTR Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-q2-2026-results-and-provides-business-u3pdcnnwyut6.html
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-q2-2026-results-and-provides-business-u3pdcnnwyut6.html
Azitra Co-founder & Chief Operating Officer, Travis Whitfill, provides the details behind the recent $10 million capital raise.
#$AZTR #Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #skinmicrobiome
youtube.com/shorts/jKiXo...
#$AZTR #Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #skinmicrobiome
youtube.com/shorts/jKiXo...
Azitra's Capital Raise
YouTube video by Unboxing Biotech
youtube.com
August 10, 2026 at 4:13 PM
Azitra Co-founder & Chief Operating Officer, Travis Whitfill, provides the details behind the recent $10 million capital raise.
#$AZTR #Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #skinmicrobiome
youtube.com/shorts/jKiXo...
#$AZTR #Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #skinmicrobiome
youtube.com/shorts/jKiXo...
Azitra Co-founder & Chief Operating Officer, Travis Whitfill, enumerates the impressive group of brands involved in microbiome and #filaggrin products.
#$AZTR
youtube.com/shorts/58WFJ...
#Cosmeceuticals #SkinBarrier #Dermatology #SkincareScience #skinmicrobiome
#$AZTR
youtube.com/shorts/58WFJ...
#Cosmeceuticals #SkinBarrier #Dermatology #SkincareScience #skinmicrobiome
Filaggrin Market Opportunity
YouTube video by Unboxing Biotech
youtube.com
July 26, 2026 at 2:40 PM
Azitra Co-founder & Chief Operating Officer, Travis Whitfill, enumerates the impressive group of brands involved in microbiome and #filaggrin products.
#$AZTR
youtube.com/shorts/58WFJ...
#Cosmeceuticals #SkinBarrier #Dermatology #SkincareScience #skinmicrobiome
#$AZTR
youtube.com/shorts/58WFJ...
#Cosmeceuticals #SkinBarrier #Dermatology #SkincareScience #skinmicrobiome
🟢 #$AZTR — Clinical Readout
Positive Ex Vivo Repeat-Dose and Anti-Wrinkle Results for ATR-COSF
Azitra announced positive results from two ex vivo human skin tissue studies of its ATR-COSF supernatant containing rHDfilaggrin: a multiple-dose study showing increa…
https://biostock.app/symbols/AZTR
Positive Ex Vivo Repeat-Dose and Anti-Wrinkle Results for ATR-COSF
Azitra announced positive results from two ex vivo human skin tissue studies of its ATR-COSF supernatant containing rHDfilaggrin: a multiple-dose study showing increa…
https://biostock.app/symbols/AZTR
July 15, 2026 at 9:50 PM
🟢 #$AZTR — Clinical Readout
Positive Ex Vivo Repeat-Dose and Anti-Wrinkle Results for ATR-COSF
Azitra announced positive results from two ex vivo human skin tissue studies of its ATR-COSF supernatant containing rHDfilaggrin: a multiple-dose study showing increa…
https://biostock.app/symbols/AZTR
Positive Ex Vivo Repeat-Dose and Anti-Wrinkle Results for ATR-COSF
Azitra announced positive results from two ex vivo human skin tissue studies of its ATR-COSF supernatant containing rHDfilaggrin: a multiple-dose study showing increa…
https://biostock.app/symbols/AZTR